More than two dozen digital health companies raised late-stage mega-rounds in the first quarter of 2022, reflecting a bigger trend in the sector that's seeing investors write larger checks for Series C rounds and beyond, according to data from CB Insights and Rock Health.
Why it matters: Although the first quarter of 2022 might go down in history as the first time in a decade that health tech funding slowed, you'd never know it looking at the size of some of its biggest deals.
